Atlas Trials

Study With Intravenous Busulfan And Fludarabine Myeloablative Conditioning Regimen For HLA Identical Sibling Donor HSCT

Clinical trial NCT01683123 · COMPLETED

Trial details

NCT number
NCT01683123
Sponsor
Grupo Espanol de trasplantes hematopoyeticos y terapia celular
Status
COMPLETED
Study type
OBSERVATIONAL
Acute Myeloid LeukemiaMyelodysplastic SyndromeMyeloproliferative DisordersChronic Myeloid Leukemia
Start date
2007-07-01
Primary completion
2011-06-01
Enrollment
143

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.